Post-transplant anti-thymocyte globulin exposure predicts graft-versus-host disease and donor chimerism outcomes in reduced intensity conditioning allogeneic stem cell transplantation. [PDF]
Koo RM +5 more
europepmc +1 more source
Letermovir improves the outcome of allogenic stem cell transplantation with anti-thymocyte globulin against acute leukemia and myelodysplastic syndromes. [PDF]
Negishi S +7 more
europepmc +1 more source
Comparison of Different Rabbit Anti-Thymocyte Globulin Formulations in the Prophylaxis of Graft-Versus-Host Disease: A Systematic Review. [PDF]
Dybko J +5 more
europepmc +1 more source
Is There a Place for Anti-Thymocyte Globulin in Steroid-Refractory Acute Graft-Versus-Host Disease?? [PDF]
Spałek A +7 more
europepmc +1 more source
Aplastic Anemia with Epstein-Barr Virus Reactivation after Anti-thymocyte Globulin Therapy. [PDF]
Kawarada Y +6 more
europepmc +1 more source
Donor-Related Factors Affecting Haploidentical HSCT Outcomes in Acute Leukemia: A Single-Center Retrospective Cohort Study of a Modified Combination of Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide. [PDF]
Mashayekhi M +11 more
europepmc +1 more source
Anti-thymocyte globulin-resistant CD4<sup>+</sup> memory T cells contribute to haplo-fever after allogeneic hematopoietic stem cell transplantation. [PDF]
Huang H +7 more
europepmc +1 more source
Anti-Thymocyte Globulin Treatment of Steroid-Refractory T-Cell Hepatitis in Children: A Case Series. [PDF]
Farr R +5 more
europepmc +1 more source
Comparing two different doses of anti-thymocyte globulin in allogeneic hematopoietic stem cell transplantation for transfusion-dependent thalassemia: an open-label, randomized clinical trial. [PDF]
Huang Q +17 more
europepmc +1 more source
Optimizing anti-thymocyte globulin dosing in allogeneic hematopoietic stem cell transplantation: individualized approaches and clinical implications. [PDF]
Wang H, Yang H, Du J, Dou L, Liu D.
europepmc +1 more source

